Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.3800 |
| Open | 1.3600 |
| Bid | 1.3500 x 27000 |
| Ask | 1.3800 x 36100 |
| Day's range | 1.3150 - 1.4000 |
| 52-week range | 1.1600 - 6.8800 |
| Volume | |
| Avg. volume | 6,417,796 |
| Market cap | 388.194M |
| Beta (5Y monthly) | 2.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3280 |
| Earnings date | 02 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.67 |
- Simply Wall St.
Shareholders in Bionano Genomics (NASDAQ:BNGO) are in the red if they invested a year ago
Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every...
- Motley Fool
Bionano Genomics, Inc (BNGO) Q1 2022 Earnings Call Transcript
At this time, I would like to turn the conference over to Amy Conrad from investor relations. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. After market closed today, Bionano issued a press release announcing its financial results for the first quarter of 2022.
- Zacks
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -37.50% and 5.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
